Rituximab-associated immune myelopathy

被引：24
作者：
Papadaki, T
Stamatopoulos, K
Anagnostopoulos, A
Fassas, A
机构：
来源：
BLOOD | 2003年 / 102卷 / 04期
关键词：
D O I：
10.1182/blood-2003-05-1532
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1557 / 1558
页数：2
相关论文
共 11 条
  • [1] Abruzzese E, 1999, BLOOD, V94, P1814
  • [2] Bienvenu J, 2001, Hematol J, V2, P378, DOI 10.1038/sj.thj.6200133
  • [3] Coakley G, 2000, ARTHRITIS RHEUM, V43, P834, DOI 10.1002/1529-0131(200004)43:4<834::AID-ANR14>3.0.CO
  • [4] 2-H
  • [5] Anti-CD20-based therapy of B cell lymphoma: state of the art
    Kosmas, C
    Stamatopoulos, K
    Stavroyianni, N
    Tsavaris, N
    Papadaki, T
    [J]. LEUKEMIA, 2002, 16 (10) : 2004 - 2015
  • [6] Liu JH, 2000, BLOOD, V95, P3219
  • [7] Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies
    Micallef, INM
    Lillington, DM
    Apostolidis, J
    Amess, JAL
    Neat, M
    Matthews, J
    Clark, T
    Foran, JM
    Salam, A
    Lister, TA
    Rohatiner, AZS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (05) : 947 - 955
  • [8] Papadaki T, 2002, BLOOD, V100, p353A
  • [9] Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two cases
    Papadaki, T
    Stamatopoulos, K
    Stavroyianni, N
    Paterakis, G
    Phisphis, M
    Stefanoudaki-Sofianatou, K
    [J]. LEUKEMIA RESEARCH, 2002, 26 (06) : 597 - 600
  • [10] Agranulocytosis unresponsive to growth factors following rituximab in vivo purging
    Rose, AL
    Forsythe, AM
    Maloney, DG
    [J]. BLOOD, 2003, 101 (10) : 4225 - 4226
12